Vaccination

US awards $1.6 billion to Novavax for COVID-19 vaccine

The US on Tuesday announced it was providing $1.6 billion in funding for the development and manufacture of a COVID-19 vaccine candidate produced by biotech firm Novavax, the largest amount awarded under Operation Warp Speed.

Diseases, Conditions, Syndromes

Testing tuberculosis vaccine combinations for COVID-19

Researchers at the University of Sydney and Centenary Institute are repurposing an existing tuberculosis vaccine to see if it can be used in a new way against COVID-19 to develop a novel vaccine.

Diseases, Conditions, Syndromes

Pfizer reports encouraging, very early vaccine test results

The first of four experimental COVID-19 vaccines being tested by Pfizer and its German partner BioNTech showed encouraging results in very early testing of 45 people, the companies said Wednesday.

Diseases, Conditions, Syndromes

Distributing a COVID-19 vaccine raises complex ethical issues

With something in the order of 150 COVID-19 vaccine candidates now in different stages of testing and development, a global public health strategy needs to be thinking several steps ahead, beyond the science. Once a vaccine ...

page 20 from 40